Phosphorylation patterns of fetuin-A in CSF and serum.

Fig 3 displays the results of the statistical analysis of the phosphorylation studies. (A) and (B) show relative CSF phosphofetuin-A concentrations (y-axis, %) in comparison to the CSF albumin/serum albumin quotient (A, x-axis, x103) and in the presence of neuroinflammatory diseases (B). (C) and (D) show absolute phosphofetuin-A levels in CSF (y-axis, μg/ml) in comparison to the CSF albumin/serum albumin quotient ((C), x-axis, x103) and a blood-CSF barrier disruption ((D), x-axis). (E) and (F) display the results of the linear regression with the relative CSF phosphofetuin-A/relative serum phosphofetuin-A quotient. This quotient is shown on the y-axis. (E) shows a scatter plot with the CSF albumin/serum albumin quotient (x-axis, x103). In (E) the results are shown divided into control group (black) and inflammatory group (white). (F) shows the correlation of the CSF phosphofetuin-A/serum phosphofetuin-A quotient with the presence of a neuroinflammatory disorder (x-axis).